Suchergebnisse - "Rastogi, Priya"

PubPharm (137)

1

Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer : analyses from the monarchE study

enthalten in: NPJ breast cancer | 2024

von Goetz, M. | Cicin, I. | Testa, L. | +12

2

Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology])

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Geyer, C. | Blum, J. | Yothers, G. | +18

3

Patient-Reported Outcomes in OlympiA : A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Ganz, P. | Bandos, H. | Španić, T. | +43

4

Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer : Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Rastogi, P. | O'Shaughnessy, J. | Martin, M. | +20

5

Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Mamounas, E. | Bandos, H. | Rastogi, P. | +15

6

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32 : A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Goodwin, P. | Chen, B. | Gelmon, K. | +16

7

Ten-year update : NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer

enthalten in: Journal of the National Cancer Institute | 2023

von Mamounas, E. | Bandos, H. | Rastogi, P. | +13

CommentIn: J Natl Cancer Inst. 2023 Jun 30;:. - PMID 37480258

8

Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41

enthalten in: Breast cancer research and treatment | 2023

von Rastogi, P. | Tang, G. | Hassan, S. | +16

9

Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer - Authors' reply

enthalten in: The Lancet. Oncology | 2023

von Johnston, S. | Tolaney, S. | O'Shaughnessy, J. | +3

CommentOn: Lancet Oncol. 2023 Jun;24(6):589-593. - PMID 37146621

10

Pathologic complete response and individual patient prognosis after neoadjuvant chemotherapy plus anti-human epidermal growth factor receptor 2 therapy of human epidermal gowth factor receptor 2-positive early breast cancer

enthalten in: Journal of clinical oncology | June 01, 2023

von Mackelenbergh, M. | Loibl, S. | Untch, M. | +26

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]